Zum Inhalt springen

Curriculum Vitae Eva Meisenzahl

Univ.-Prof. Dr. Eva Meisenzahl

Foto von Eva Meisenzahl
Bild-Großansicht

1. Education/Training

11/1992
State Examination, Faculty of medicine, Free University of Berlin, Germany

1992-1993
Residency, Dept. Neurology, TWW Berlin, Germany
Licensed to practice medicine (‘Approbation’)

1994-1996
Dual Residency, Dept. Neuroradiology and Dept. Psychiatry, Charité Berlin, Humboldt University (HU)

1996-2003
Residency, University Hospital of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) Medical Faculty LMU Munich

2. Positions and Honors

Positions and Employment

2003
Consultant in psychiatry and psychotherapy

2004 – 2016
Senior physician University Hospital of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) Medical Faculty, LMU Munich

2006 - 2016
Managing senior physician of the hospital & Responsible for giving the mandatory Teaching to the faculty of Psychology in psychopathology and clinical psychiatry, LMU Munich

2006 – 2013
Manager of the entire Education & Teaching programme for all modules in the specialty Psychiatry and Psychotherapy (MeCuM, Medical Curriculum Munich, teaching offerings in the Centre for Teaching and Studies, LMU Munich

2010 – 2016
W2 Full-Professor of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) member of the faculty of medicine Department of Psychiatry, LMU, Munich, Germany, unlimited contract

2015
Call to head position of director of the department of psychiatry university of Düsseldorf, HHU; Call to head position of director of the department of psychiatry university of Linz, JPU; Call to head position of director of the department of psychiatry university of Kiel,CAU.

Since 2016
Professor of Psychiatry, Chair (Director) of the Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, LVR-Klinikum Düsseldorf

Memberships

Member of

  • German Association for Psychiatry, Psychotherapy, Psychosomatics and Neurology (DGPPN),member workgroup predictive Psychiatry & member social psychiatry
  • AGNP Working Group on Neuropharmacology
  • DGBP German Society of Biological Psychiatry
  • LIPPS National Association of Chairs of Psychiatry
  • 5. ESAS European Scientific Association on Schizophrenia and other Psychoses
  • European Association of Psychiatry, member Workgroup Neuroimaging
  • European Association of Neuropsychopharmacology, member Workgroup Neuroimaging
  • Member of the expert group for the development of the S3-Schizophrenia Clinical Guideline (Ed. DGPPN/AWMF); contribution to the topic: Early recognition and early intervention/ focus: brain imaging
  • DÄVT, German medical Sociaty in cognitive behavioral therapy, certified supervisior
  • DHV, German university association

Other experience and professional memberships

  • Vice President, ESAS European Scientific Association on Schizophrenia and other Psychoses
  • Chairman of the Alliance against Depression Düsseldorf
  • President of ELAN e.V., association for citizen assistence
  • Medical Director of the psychiatric hospital LVR Düsseldorf (2016-2020)
Abbildung der Urkunde des Bristol-Myers Award 2011
Bild-Großansicht
EUROPEAN BRISTOL-MYERS SQUIBB PREVENTION AWARD IN PSYCHIATRY 2011

Awards/ Honors
Patents

  • Scientific Scholarship holder of the LMU Munich (2001-2003) (180.000 Euro/2 years)
  • National Prize Winner of the Von Gudden Preis (2002) (5000 Euro)
  • National Prize Winner of the Hormosan Prize (2008) (10.000 Euro)
  • International Prize Winner of the European Prevent Prize, Association of European Psychiatry (2011) (20.000 Euro)
  • Honorary appointment as Senior Research Fellow of the Bedfordshire Center for Mental Health Research, University of Cambridge (2011)
  • US Patent Adaptive pattern recognition for psychosis risk modelling US20160192889A1

3. Selected peer reviewed grants

During the last 5 years scientific projects funded with 7.021.665 Euro. The complete project list can be provided if required. Ongoing research support
Short title Funding institution Start/End Applicants Total funding [€]
Personalised Prognostic Tools for Early Psychosis Management” (PRONIA) EU 7th Framework 07/13 -onging PI Meisenzahl, Koordinator Koutsouleris 6 Mio. Euro
Suicide Prevention Risk Management Alliance / Suizid Präventions-Risikomanagement Allianz:
Development of an E Health Teaching programme (SUPRIMA)
German Ministry of Health 10/17-ongoinig PI Meisenzahl
676.838

4. Selection of peer-reviewed publications

Title
Multi-modal Workflows for Psychosis Prediction in Clinical High-Risk Syndromes and Recent-Onset Depression: A Multi-Site Machine Learning Analysis. Last author, JAMA Psychiatry, accepted
IF: 17.472
Neuroanatomical pattern classification identifies subjects in at risk mental state of psychosis and predicts disease transition. First author, Archives of General Psychiatry
2009, 66 (7): 700-712. (FA equally contributed)
IF: 16.642
Plexin B3 is genetically associated with verbal performance and white matter volume in brain. First author, Molecular Psychiatry 2007, 12 (2): 190-194. IF: 10.009
Brain Derived Neurotrophic Factor Val66met and Serotonin Transporter Promoter Region Polymorphisms are differently associated with reduced hippocampal volumes in major depression. Last Author, Archives of General Psychiatry 2007, 64:410 – 416. (FA equally contributed)
IF: 15.976
Depression-related long-term Decline of Brain Morphology: Stress-toxicity? Last author, Archives of General Psychiatry 2008, 65(10):1156-65.
IF: 15.976
Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. First author, Brain 2015. 138:2059-73
IF: 10.226 . (FA equally contributed)
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Last author, Mol Psychiatry 2008, 13(12):1093-101.
IF: 12.537
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Last author, Schizophr Bull 2012, 38(6):1200-15.
IF: 8.486
Distinguishing Prodromal From First-Episode Psychosis Using Neuroanatomical Single-Subject Pattern Recognition. Last author, Schizophr Bull 2012 38(5):11-18
IF: 8.486
Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders. Last author, Schiz Bulletin 2014, 40(5):1140-53 IF: 8.486
Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: A multi- modal, multisite machine learning analysis. Middle author, JAMA Psychiatry 2018, 75(11):1156-1172.
IF: 17.472

Nach oben